Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Bond Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113354498B enables metal-free deuteration. Enhances supply chain reliability and reduces manufacturing costs for high-purity pharmaceutical intermediates.
Novel ligand-free CuCl catalyzed trifluoromethylation method offers cost reduction and scalable production for pharmaceutical intermediates supply chain.
Patent CN110981919A details a one-pot C-H activation route for eight-membered palladacycles, offering significant cost reduction in organometallic catalyst manufacturing.
Patent CN118344279B enables metal-free indole synthesis. Reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates globally.
Novel Pd-catalyzed C-H activation method for 3-ester indoles. High yield ≥95%wt. Cost-effective scalable process for pharmaceutical intermediates.
Novel C-H activation method for Acyclovir and Ganciclovir synthesis. Delivers high yield, cost-effective production, and scalable supply chain solutions for global pharmaceutical manufacturers seeking reliable intermediates.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.
Patent CN114507180A reveals an iodine-catalyzed method for synthesizing bis-heteroaryl ethylenes with 90% yield, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN118619818A reveals mild Pd-catalyzed iodination technology. Enhances supply chain reliability for pharmaceutical intermediates. Offers high yield and functional group tolerance for scalable manufacturing processes.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Novel iron-catalyzed C-H/N-H activation route for pyrrolo[1,2-a]indole alkaloids. Cost-effective, scalable pharma intermediate synthesis with high purity.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Patent CN109776546B details a high-yield Re-catalyzed synthesis of indolopyrrolones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Palladium-catalyzed C-H activation method enables high-purity 3-iminoisoindolinone production with significant cost reduction and reliable supply chain for pharmaceutical manufacturers.